Metjian Talene A, Prasad Priya A, Kogon Amy, Coffin Susan E, Zaoutis Theoklis E
Department of Pharmacy Services, The Children's Hospital of Philadelphia, PA 19104, USA.
Pediatr Infect Dis J. 2008 Feb;27(2):106-11. doi: 10.1097/INF.0b013e318158603a.
Thirty to 50% of hospitalized patients receive antimicrobial therapy. Previous data suggest that inappropriate use results in higher mortality rates, longer lengths of stay, and increased medical costs. Antimicrobial Stewardship Programs (ASPs) reduce the improper use of antimicrobials and improve patient safety. Despite increased awareness about the benefits of these programs, few pediatric ASPs exist and fewer comprehensive studies evaluate their effects.
A prospective observational study was conducted to describe the use and impact of a pediatric ASP. Data were collected on the clinician's request for targeted antibiotics and the interventions made by the ASP. Retrospective chart review was performed to assess outcomes and compliance on empiric antimicrobial therapy decisions and recommendations to discontinue antimicrobial therapy.
During the 4-month study period, calls were placed to the ASP for 652 patients. Forty-five percent of those calls required an intervention by the ASP. These interventions included: (1) Targeting the known or suspected pathogens (20%); (2) Consultation (43%); (3) Optimize antimicrobial treatment (33%); and (4) Stop antimicrobial treatment (4%). Three of the 84 (3.5%) patients recommended to receive alternative therapy developed an infection not covered by the ASP recommendations or the antimicrobial initially requested by the clinician.
Our data demonstrate that an ASP improves the appropriate use of antimicrobial medications in hospitalized children. In addition, the ASP plays an integral role in providing guidance to clinicians and ensures that the appropriate antimicrobial agents are used.
30%至50%的住院患者接受抗菌治疗。既往数据表明,不当使用会导致更高的死亡率、更长的住院时间和增加医疗成本。抗菌药物管理计划(ASP)可减少抗菌药物的不当使用并提高患者安全性。尽管人们对这些计划的益处的认识有所提高,但儿科ASP却很少,而且很少有全面的研究评估其效果。
进行了一项前瞻性观察性研究,以描述儿科ASP的使用情况及其影响。收集了关于临床医生对靶向抗生素的请求以及ASP所采取干预措施的数据。进行回顾性病历审查,以评估经验性抗菌治疗决策和停止抗菌治疗建议的结果及依从性情况。
在为期4个月的研究期间,共为652名患者致电ASP。其中45%的致电需要ASP进行干预。这些干预措施包括:(1)针对已知或疑似病原体(20%);(2)会诊(43%);(3)优化抗菌治疗(33%);以及(4)停止抗菌治疗(4%)。在84名(3.5%)被建议接受替代治疗的患者中,有3名患者发生了ASP建议或临床医生最初要求使用的抗菌药物未覆盖的感染。
我们的数据表明,ASP可改善住院儿童抗菌药物的合理使用。此外,ASP在为临床医生提供指导方面发挥着不可或缺的作用,并确保使用适当的抗菌药物。